Adil Daud
@ad1600
history, art, literature and clinical researcher immunotherapy esp melanoma
ID:28265240
http://cancer.ucsf.edu/people/daud_adil.php 02-04-2009 02:49:08
2,4K Tweets
936 Followers
1,0K Following
On Capitol Hill today @ASCOCancer to talk to our Members of Congress about legislation that impacts the quality of oncology and research. #ASCOAdvocacySummit @Northwesternmedicine Lurie Cancer Center
A special evening today: Dr. Pamela Munster gets endowed with Mariam Moghadam Safinia distinguished professorship in hereditary cancer research
UCSF Helen Diller Family Comprehensive Cancer Ctr #breastcancer #Oncology #researchers
Excited to share our manuscript on single-cell and spatial multi-omics of anti-integrin therapy in ulcerative colitis (UC) nature.com/articles/s4146…. This work was led by Elvira Mennillo, in collaboration with Alexis Combes, @GabiFragiadaks, and Angela Oliveira Pisco 1/8
Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in #sarcoma ! #AlveolarSoftPartSarcoma is a rare cancer! Thanks for this Dr. Monica M. Bertagnolli’s award! My last for work I did NCI CTEP Clinical Research! Thanks to @NIH, Genentech & FDA Oncology
I am truly honored to have received the Moffitt Cancer Center Physician of the Year . But it really is a team effort with the fellows, APPs, nurses, admins, and others who team up with me to take care of our patients day after day. Moffitt Cancer Center Thank you for the recognition ❤️
Huge news and a win for patients with #melanoma seeking #immunotherapy ! Omid Hamid MD Katy Tsai, MD Adil Daud
Join us for an exciting pan-UC discussion of all things melanoma. Saturday Feb17th morning. Discussion of what makes melanoma tick and advances in therapy UC San Francisco UC San Diego Health UCLA Health UC Irvine UC Davis Health
Certainly an important question! Cost-effectiveness should also be considered for choosing between 1st-line melanoma rx without head-to-head comparative data [see our attached SMR poster by Hiba Khan MD MPH Evan Hall Veena Shankaran MD, MS] Common Sense Oncology Melanoma Research Foundation Society for Immunotherapy of Cancer
I am also thrilled that Ajay Maker has been named to this critical UC San Francisco leadership position.
It has been a great privilege to work with Ajay since my return to UC San FranciscoCancer to improve interdisciplinary #cancer programs. I’m looking forward to all we will accomplish together!
‼️We are eager to share that, following a comprehensive search, Dr. Ajay Maker Ajay Maker has been named Surgeon in Chief for the Helen Diller Family Comprehensive UCSF Helen Diller Family Comprehensive Cancer Ctr Center. This appointment marks the creation of a new & significant role within the organization 🥳🥳